{"transactions":[{"id":1033907,"issuer":{"id":7525,"kind":"organization","name":"Lantern Pharma Inc."},"owners":[{"id":75041,"kind":"person","name":"SHARMA PANNA","position":1,"cik":"0001157989","reported_name":"SHARMA PANNA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-23T16:05:16.000Z","date":"2020-06-15","kind":"grant","planned":false,"acquired":true,"shares":76628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involve an amendment of an outstanding option for purposes of reducing the option exercise price, resulting in the cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on June 15, 2020 and one-third of the option vested 180 days from the grant date with the remaining two-thirds of the option vesting in equal monthly increments over the period commencing the 181st day after the grant date and ending 30 months thereafter (or 36 months after the grant date)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involve an amendment of an outstanding option for purposes of reducing the option exercise price, resulting in the cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on June 15, 2020 and one-third of the option vested 180 days from the grant date with the remaining two-thirds of the option vesting in equal monthly increments over the period commencing the 181st day after the grant date and ending 30 months thereafter (or 36 months after the grant date)."}],"balance_after":76628,"derivative":{"exercise_price":5.04,"expiration_date":"2030-06-14","underlying":"Common Stock","underlying_shares":76628},"source":{"system":"sec-edgar","filing":"0001493152-25-014616","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157989/000149315225014616/ownership.xml","form_type":"4"}},{"id":1033906,"issuer":{"id":7525,"kind":"organization","name":"Lantern Pharma Inc."},"owners":[{"id":75041,"kind":"person","name":"SHARMA PANNA","position":1,"cik":"0001157989","reported_name":"SHARMA PANNA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-23T16:05:16.000Z","date":"2020-06-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":76628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involve an amendment of an outstanding option for purposes of reducing the option exercise price, resulting in the cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on June 15, 2020 and one-third of the option vested 180 days from the grant date with the remaining two-thirds of the option vesting in equal monthly increments over the period commencing the 181st day after the grant date and ending 30 months thereafter (or 36 months after the grant date)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involve an amendment of an outstanding option for purposes of reducing the option exercise price, resulting in the cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on June 15, 2020 and one-third of the option vested 180 days from the grant date with the remaining two-thirds of the option vesting in equal monthly increments over the period commencing the 181st day after the grant date and ending 30 months thereafter (or 36 months after the grant date)."}],"balance_after":0,"derivative":{"exercise_price":15,"expiration_date":"2030-06-14","underlying":"Common Stock","underlying_shares":76628},"source":{"system":"sec-edgar","filing":"0001493152-25-014616","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157989/000149315225014616/ownership.xml","form_type":"4"}},{"id":1452868,"issuer":{"id":7525,"kind":"organization","name":"Lantern Pharma Inc."},"owners":[{"id":75041,"kind":"person","name":"SHARMA PANNA","position":1,"cik":"0001157989","reported_name":"SHARMA PANNA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-17T16:30:19.000Z","date":"2024-07-15","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options will vest and first become exercisable in equal monthly increments over a 24-month period commencing August 15, 2024."}],"balance_after":70000,"derivative":{"exercise_price":4.35,"expiration_date":"2034-07-15","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001493152-24-028187","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157989/000149315224028187/ownership.xml","form_type":"4"}},{"id":2191190,"issuer":{"id":7525,"kind":"organization","name":"Lantern Pharma Inc."},"owners":[{"id":75041,"kind":"person","name":"SHARMA PANNA","position":1,"cik":"0001157989","reported_name":"SHARMA PANNA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-09T16:26:49.000Z","date":"2022-08-06","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options will vest and first become exercisable in equal monthly increments over a 36-month period commencing September 8, 2022, with the vesting of the options to accelerate in the event the closing price for our common stock is at least $15.00 per share."}],"balance_after":100000,"derivative":{"exercise_price":5.6,"expiration_date":"2032-08-06","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-22-045909","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157989/000121390022045909/ownership.xml","form_type":"4"}},{"id":3110784,"issuer":{"id":7525,"kind":"organization","name":"Lantern Pharma Inc."},"owners":[{"id":75041,"kind":"person","name":"SHARMA PANNA","position":1,"cik":"0001157989","reported_name":"SHARMA PANNA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Stock Option","published_at":"2020-06-15T17:34:48.000Z","date":"2020-06-15","kind":"grant","acquired":true,"shares":76628,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to an amendment to the Reporting Person's employment agreement, the Reporting Person was granted stock options to purchase 76,628 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (\"IPO\") at an exercise price per share equal to the price per share sold in the Issuer's IPO. One third of the options will vest 180 days after the closing of the Issuer's IPO (the \"Grant Date\"), with the remaining two thirds of the options vesting in equal monthly increments over a thirty (30) month period commencing the 181st day after the Grant Date. All other terms and conditions of the option grant will be consistent with the terms and conditions permitted under the Issuer's Amended and Restated 2018 Equity Incentive Plan. Under the Amended and Restated 2018 Equity Incentive Plan, the options may not be exercised after the tenth anniversary of the Grant Date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to an amendment to the Reporting Person's employment agreement, the Reporting Person was granted stock options to purchase 76,628 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (\"IPO\") at an exercise price per share equal to the price per share sold in the Issuer's IPO. One third of the options will vest 180 days after the closing of the Issuer's IPO (the \"Grant Date\"), with the remaining two thirds of the options vesting in equal monthly increments over a thirty (30) month period commencing the 181st day after the Grant Date. All other terms and conditions of the option grant will be consistent with the terms and conditions permitted under the Issuer's Amended and Restated 2018 Equity Incentive Plan. Under the Amended and Restated 2018 Equity Incentive Plan, the options may not be exercised after the tenth anniversary of the Grant Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to an amendment to the Reporting Person's employment agreement, the Reporting Person was granted stock options to purchase 76,628 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (\"IPO\") at an exercise price per share equal to the price per share sold in the Issuer's IPO. One third of the options will vest 180 days after the closing of the Issuer's IPO (the \"Grant Date\"), with the remaining two thirds of the options vesting in equal monthly increments over a thirty (30) month period commencing the 181st day after the Grant Date. All other terms and conditions of the option grant will be consistent with the terms and conditions permitted under the Issuer's Amended and Restated 2018 Equity Incentive Plan. Under the Amended and Restated 2018 Equity Incentive Plan, the options may not be exercised after the tenth anniversary of the Grant Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to an amendment to the Reporting Person's employment agreement, the Reporting Person was granted stock options to purchase 76,628 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (\"IPO\") at an exercise price per share equal to the price per share sold in the Issuer's IPO. One third of the options will vest 180 days after the closing of the Issuer's IPO (the \"Grant Date\"), with the remaining two thirds of the options vesting in equal monthly increments over a thirty (30) month period commencing the 181st day after the Grant Date. All other terms and conditions of the option grant will be consistent with the terms and conditions permitted under the Issuer's Amended and Restated 2018 Equity Incentive Plan. Under the Amended and Restated 2018 Equity Incentive Plan, the options may not be exercised after the tenth anniversary of the Grant Date."}],"balance_after":76628,"derivative":{"exercise_price":15,"underlying":"Common Stock","underlying_shares":76628},"source":{"system":"sec-edgar","filing":"0001213900-20-015051","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157989/000121390020015051/ownership.xml","form_type":"4"}},{"id":4424954,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":75041,"kind":"person","name":"SHARMA PANNA","position":1,"cik":"0001157989","reported_name":"SHARMA PANNA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-24T17:00:21.000Z","date":"2017-02-22","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest in 48 equal monthly installments commencing on the date of grant until fully vested, provided that the reporting person remains a service provider to Cancer Genetics, Inc. through each applicable vesting period."}],"balance_after":200000,"derivative":{"exercise_price":2.5,"expiration_date":"2027-02-22","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001349929-17-000019","document":"wf-form4_148797360556721.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157989/000134992917000019/wf-form4_148797360556721.xml","form_type":"4"}}]}